Study focus area

OUR STUDIES

IMPLEMENTATION OF MOBILE HEALTH TECHNOLOGY SERVICES WITHIN THE MUSC INFECTIOUS DISEASES CLINIC TO ENHANCE LINAGE AND RETENTION IN CARE FOR PATIENTS LIVING WITH HIV

Background

Based on clinical experience, the investigators suspect that many patients may have greater comfort and accessibility with text messages and/or video conferencing platforms than with traditional phone calls. Mobile health strategies have the potential to connect health care entities and patients, augment in-clinic interactions, and improve access. Investigators at the University Medical University of South Carolina (MUSC) Infectious Disease Clinic hypothesize that the capacity to text and video conference with the people living with HIV cared for at MUSC will improve linkage to care, retention in care, and patient satisfaction.

Design

The design of this study is an interrupted time series with a mixed methods formative evaluation. In Phase 1, a developmental formative evaluation takes place with a sample of 14 clinic staff and 12 patients.

In Phase 2, any patient receiving case management services in the HIV clinic will be eligible for enrolment in text/video chat medical services. An interpretive formative evaluation will take place In Phase 3.

Challenges
Exemplary Quotes
Impersonality " I feel as tough texting loses  emotion...People don't see my concern over text." -Medical Provider
Expectations of instant access (provider) "...Texting implies that you have my full attention and I'm at your disposal anytime, anywhere." -Medical Provider
Potential for overutilization (provider) "...Please don't send me 15 text messages in one day." -Social Support Provider
Privacy and security "There's always an element of concern for someone who's HIV positive that somebody's going to find out their status that they don't want to know their status." -Social Support Provider
Cost and access "...Some people have monthly bills for phone plans. They have unlimited. Some people have minutes and stuff. " -African American male patient, 33 years old.

Primary objective

  • Assess the clinical effectiveness of implementing bidirectional text and video conferencing capacity on linkage and retention in care among people living with HIV receiving MUSC-based outreach or case management services

Results

  • Some patients wanted medical information sent by text, not others
  • Providers wanted short, general messages
  • Patients and providers liked using texting for quick check-ins

Collaborators

Dr. Eric Meisser

Dr. Virginia Fonner

Setting

University Medical Infectious Disease Clinic

Location

U.S.A.

Duration

June 2019 – May 2020

Key study materials

ViiV study lead and contact

Tammeka Evans,
Director of Global Public Health and Innovation

Contact

RELATED STUDIES

USA

As part of an effort to re-engage patients into care, this study determined the effectiveness of using an outreach nurse as a direct clinical liaison through the State Bridge Counsellor (SBC) Program.

USA

To aid future research on the effectiveness of the U=U message campaign as a clinical intervention, the aim of this project is to evaluate the effectiveness of a clinic-delivered media campaign of the U=U message.

BRAZIL

This study demonstrated how the effective implementation of a clinical care monitoring system increased the number of patients engaged across the care continuum and improved patient outcomes.

Our partnerships

Our partnerships

We are proud to partner with multiple organizations that work to prevent HIV and improve the lives of people who live with HIV.

Find out more

NP-GBL-HVU-COCO-230001 | August 2023

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.